Misplaced Pages

Psychobiotic: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editContent deleted Content addedVisualWikitext
Revision as of 02:45, 6 December 2018 editCamilleGreenberg90 (talk | contribs)19 edits →Species: Added a species known to act as a psychobioticTag: Visual edit← Previous edit Latest revision as of 01:17, 23 November 2024 edit undoViriditas (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers169,133 edits move section 
(37 intermediate revisions by 20 users not shown)
Line 1: Line 1:
{{Short description|Microorganisms giving mental health effects}}
Psychobiotics are live organisms that, when ingested in appropriate amounts, confer a mental health benefit through association with the commensal bacteria of gut of the host organism <ref name=":0" /> . The aforementioned commensal bacteria play a key role in the bidirectional gut-brain axis. Psychobiotics can be subdivided into ], ], and ].
{{medref|date=December 2018}}

'''Psychobiotics''' is a term used in preliminary research to refer to ] that, when ingested in appropriate amounts, might confer a ] benefit by affecting ] of the host organism.<ref name="Sarkar_2016" /> Whether bacteria might play a role in the ] is under research. A 2020 literature review suggests that the consumption of psychobiotics could be considered as a viable option to restore mental health<ref>{{Cite journal |title=Psychobiotics: Mechanisms of Action, Evaluation Methods and Effectiveness in Applications with Food Products |year=2020 |doi=10.3390/nu12123896|pmc=7767237 |doi-access=free |last1=Del Toro-Barbosa |first1=M. |last2=Hurtado-Romero |first2=A. |last3=Garcia-Amezquita |first3=L. E. |last4=García-Cayuela |first4=T. |journal=Nutrients |volume=12 |issue=12 |page=3896 |pmid=33352789 }}</ref> although lacking ] on clear mental health outcomes in humans.<ref name="romijn">{{cite journal | vauthors = Romijn AR, Rucklidge JJ | title = Systematic review of evidence to support the theory of psychobiotics | journal = Nutrition Reviews | volume = 73 | issue = 10 | pages = 675–93 | date = October 2015 | pmid = 26370263 | doi = 10.1093/nutrit/nuv025 | doi-access = free }}</ref><ref name="lin">{{cite journal | vauthors = Liu B, He Y, Wang M, Liu J, Ju Y, Zhang Y, Liu T, Li L, Li Q | title = Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials | journal = Depression and Anxiety | volume = 35 | issue = 10 | pages = 935–45 | date = July 2018 | pmid = 29995348 | doi = 10.1002/da.22811| s2cid = 51615532 | doi-access = free }}</ref>


== Types == == Types ==
] ]
In probiotic psychobiotics, the bacteria most commonly used are ],such as the '']'' and '']'' families, as these do not contain ] ] chains, reducing the likelihood of an ].<ref name=":0">{{cite journal|vauthors=Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PW|date=November 2016|title=Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals|journal=Trends in Neurosciences|volume=39|issue=11|pages=763–781|doi=10.1016/j.tins.2016.09.002|pmc=5102282|pmid=27793434}}</ref> In experimental probiotic psychobiotics, the bacteria most commonly used are ], such as '']'' and '']'' families, as these do not contain ] chains, reducing the likelihood of an ].<ref name="Sarkar_2016">{{cite journal | vauthors = Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PW | title = Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals | journal = Trends in Neurosciences | volume = 39 | issue = 11 | pages = 763–81 | date = November 2016 | pmid = 27793434 | pmc = 5102282 | doi = 10.1016/j.tins.2016.09.002 }}</ref> ] are substances, such as ] and ], that induce the growth or activity of beneficial ]s, such as bacteria on being ] in the gut.<ref name="Sarkar_2016" /><ref name="2015defRev">{{cite journal | vauthors = Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G, Goh YJ, Hamaker B, Martens EC, Mills DA, Rastal RA, Vaughan E, Sanders ME | title = Prebiotics: why definitions matter | journal = Current Opinion in Biotechnology | volume = 37 | pages = 1–7 | date = February 2016 | pmid = 26431716 | pmc = 4744122 | doi = 10.1016/j.copbio.2015.09.001 }}</ref> Multiple bacterial species contained in a single probiotic broth is known as a polybiotic.<ref name=":5">{{cite journal | vauthors = Bambury A, Sandhu K, Cryan JF, Dinan TG | title = Finding the needle in the haystack: systematic identification of psychobiotics | journal = British Journal of Pharmacology | volume = 175 | issue = 24 | pages = 4430–38 | date = December 2018 | pmid = 29243233 | pmc = 6255950 | doi = 10.1111/bph.14127 }}</ref>


== Gut-brain axis ==
Prebiotic psychobiotics are substances, such as ] and ], promote the growth of intrinsic commensal bacteria by their fermentation in the gut.<ref name=":0" />
Psychobiotics are probiotics that influence the gut-brain axis, the bidirectional communication network linking the gastrointestinal system and the brain. By positively modulating the gut microbiota, psychobiotics can impact the production of neurotransmitters, reduce inflammation, and enhance neural signaling, which may improve mental health and alleviate symptoms of neurological disorders. This highlights their potential as a therapeutic tool for maintaining a healthy gut-brain connection.

A combination of a prebiotic and a probiotic is known as a ]. Multiple bacterial species contained in a single probiotic broth is known as a polybiotic.<ref name=":5">{{cite journal | vauthors = Bambury A, Sandhu K, Cryan JF, Dinan TG | title = Finding the needle in the haystack: systematic identification of psychobiotics | journal = British Journal of Pharmacology | date = December 2017 | pmid = 29243233 | doi = 10.1111/bph.14127 }}</ref>

== Proposed mechanisms of action ==
Pathological changes in gut microbiotia may activate pro-inflammatory pathways via the ] ] which has been identified as a potential trigger for ].<ref>{{cite journal | vauthors = Inserra A, Rogers GB, Licinio J, Wong ML | title = The Microbiota-Inflammasome Hypothesis of Major Depression | journal = BioEssays | volume = 40 | issue = 9 | pages = e1800027 | date = September 2018 | pmid = 30004130 | doi = 10.1002/bies.201800027 }}</ref>

The brain-gut axis and ] have been linked. The brain cannot store tryptophan and requires a constant supply of this substance. Reduced peripheral tryptophan levels have been associated with depressive phenotype, and tryptophan levels and availability have been found to be directly influenced by the gut microbiota with ''Bifidobacteria'' being shown to increase peripheral tryptophan in animal models. Bacteria play a role in serotonin synthesis from tryptophan in the gut ]s and germ-free mice which are treated with probiotics show threefold increases in serotonin production.<ref name=":5" />

Some intestinal microbes have been found to produce psychotropic effects in animal models by secreting ] and neurotransmitter precursor molecules such as ], ], ], ], ], and ] and also by regulating ] expression.<ref>{{Cite book | vauthors = Wall R, Cryan JF, Ross RP, Fitzgerald GF, Dinan TG, Stanton C | title = Bacterial neuroactive compounds produced by psychobiotics | journal = Advances in Experimental Medicine and Biology | volume = 817 | pages = 221–39 | date = 2014 | pmid = 24997036 | doi = 10.1007/978-1-4939-0897-4_10 | isbn = 978-1-4939-0896-7 }}</ref><ref>{{Cite journal|last=Hsiao|first=E|last2=McBride|first2=S.W.|last3=Hsien|first3=S|last4=Sharo|first4=G|last5=Hyde|first5=E.R.|last6=McCue|first6=T|date=2013|title=Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders|url=|journal=Cell|volume=151|pages=1451-1463|via=}}</ref>


== Research == == Research ==
A 2021 review showed that treating anxiety in young people with psychobiotics had no significant effect.<ref name="cohen">{{Cite journal|last1=Cohen Kadosh|first1=Kathrin|last2=Basso|first2=Melissa|last3=Knytl|first3=Paul|last4=Johnstone|first4=Nicola|last5=Lau|first5=Jennifer Y. F.|last6=Gibson|first6=Glenn R.|date=2021-06-16|title=Psychobiotic interventions for anxiety in young people: a systematic review and meta-analysis, with youth consultation|journal=Translational Psychiatry|language=en|volume=11|issue=1|page=352 |doi=10.1038/s41398-021-01422-7|issn=2158-3188|pmc=8206413|pmid=34131108}}</ref> This study highlights the gut microbiome's role in brain function and mental health is a growing research area, particularly during adolescence, a critical period for gut-brain axis development. This study systematically reviewed and analyzed the effects of psychobiotic interventions on anxiety in youth (ages 10–24). Among 5416 studies identified, 14 were reviewed, and 10 included in the meta-analysis, involving 617 participants. The results showed minimal efficacy of psychobiotics in reducing anxiety, with a pooled standard mean difference of −0.03, indicating no significant effect. Despite limited evidence, future research focusing on mechanisms, causality, and youth perspectives is essential for advancing psychobiotic use in mental health management.
As of 2018, there had been several clinical trials of psychobiotics; reviews of these trials concluded that there is no good evidence that psychobiotics are safe and effective in humans.<ref>{{cite journal | vauthors = Romijn AR, Rucklidge JJ | title = Systematic review of evidence to support the theory of psychobiotics | journal = Nutrition Reviews | volume = 73 | issue = 10 | pages = 675–93 | date = October 2015 | pmid = 26370263 | doi = 10.1093/nutrit/nuv025 | url = https://academic.oup.com/nutritionreviews/article/73/10/675/1848054 }}</ref><ref>{{cite journal | vauthors = Liu B, He Y, Wang M, Liu J, Ju Y, Zhang Y, Liu T, Li L, Li Q | title = Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials | journal = Depression and Anxiety | volume = 35 | issue = 10 | pages = 935–945 | date = July 2018 | pmid = 29995348 | doi = 10.1002/da.22811 }}</ref>


Another article highlights how the nervous system disorders affect millions globally each year, sparking interest in the potential of probiotics to support the gut-brain axis alongside traditional treatments. Psychobiotics, a type of probiotic, have shown promise in improving gut microbiota and alleviating symptoms of central nervous system (CNS) disorders. This study reviewed their impact on conditions like autism spectrum disorders, Parkinson's disease, multiple sclerosis, depression, and insomnia, among others. The findings suggest that psychobiotic-containing functional foods could be an effective tool for improving mental health and managing CNS disorders.
Preclinical studies have been conducted in ] such as rats and mice. ] demonstrate heightened physiological reactions to psychological stress compared to animals with a normal microbiome, and that these phenomena were reversible by promoting the formation of a healthy microbiome using probiotic treatment.<ref name=":0" /> Psychobiotic treatment of mice exposed to a ] model of anxiety and depression has been found to prevent the fall in physical performance and raised pro-inflammatory ] levels associated with untreated mice, and treatment of mice with '']'' probiotics has been found to reduce activation of the ] in similar circumstances. These mice also expressed fewer depressive and anxious behaviors.<ref name=":0" /> In a similar maternal stress model the psychobiotic species '']'' was able to reduce corticosterone markers of increased HPA axis activity in mice.<ref name=":6">{{cite journal | vauthors = Liu YW, Liong MT, Tsai YC | title = New perspectives of Lactobacillus plantarum as a probiotic: The gut-heart-brain axis | journal = Journal of Microbiology | volume = 56 | issue = 9 | pages = 601–613 | date = September 2018 | pmid = 30141154 | doi = 10.1007/s12275-018-8079-2 }}</ref>


There is a need for more diverse human studies, mainly because those that exist have contradictory outcomes.<ref name="romijn" /><ref name="lin" /><ref name="cohen" />
Bimuno-GOS and FOS prebiotic supplementation has been found to have neuroprotective activity in animal models, and to raise BDNF levels in the ].<ref name=":5" /> Short chain fatty acids (SCFAs) such as ], ] and ] are produced in increased amounts following administration of prebiotics in animal models. Butyrate has been demonstrated to have antidepressant effects, can cross the ], and has neuroprotective activity. SCFAs also affect the local gut mucosal immune system, a potential mechanism by which modulation of the HPA axis may occur.<ref name=":5" />


⚫ ===Species===
There is a correlation between eating a ] over a long period of time and a reduced risk of major depressive disorder;<ref>{{cite journal |last1=Psaltopoulou |first1=T |last2=Sergentanis |first2=TN |last3=Panagiotakos |first3=DB |last4=Sergentanis |first4=IN |last5=Kosti |first5=R |last6=Scarmeas |first6=N |title=Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis. |journal=Annals of Neurology |date=October 2013 |volume=74 |issue=4 |pages=580–91 |doi=10.1002/ana.23944 |pmid=23720230}}</ref> a 2017 review suggested that analysis of the gut flora of people on such diets might identify bacterial strains with potential psychobiotic activity.<ref name=":5" />

⚫ == Species ==
] ]
Several species of bacteria have been used in probiotic psychobiotic preparations:<ref name=":5" /><ref name=":6" /> Several species of bacteria have been used in probiotic psychobiotic research:<ref name=":5" /><ref>{{cite journal | vauthors = Dinan TG, Stanton C, Cryan JF | title = Psychobiotics: a novel class of psychotropic | journal = Biological Psychiatry | volume = 74 | issue = 10 | pages = 720–26 | date = November 2013 | pmid = 23759244 | doi = 10.1016/j.biopsych.2013.05.001 | s2cid = 40059439 }}</ref>


* ] * ]
Line 39: Line 32:
* ] * ]
*] *]
*'']''


== References == == References ==
{{reflist}}
<references />

==Further reading==
* {{cite book|title=The Psychobiotic Revolution|publisher=Random House US|first1=Scott C.|last1=Anderson|first2=John F.|last2=Cryan|first3=Ted|last3=Dinan|date=17 December 2019|edition=1|isbn=9781426219641}}


{{Dietary supplement}} {{Dietary supplement}}
Line 48: Line 45:
] ]
] ]
]

Latest revision as of 01:17, 23 November 2024

Microorganisms giving mental health effects
This article needs more reliable medical references for verification or relies too heavily on primary sources. Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "Psychobiotic" – news · newspapers · books · scholar · JSTOR (December 2018)

Psychobiotics is a term used in preliminary research to refer to live bacteria that, when ingested in appropriate amounts, might confer a mental health benefit by affecting microbiota of the host organism. Whether bacteria might play a role in the gut-brain axis is under research. A 2020 literature review suggests that the consumption of psychobiotics could be considered as a viable option to restore mental health although lacking randomized controlled trials on clear mental health outcomes in humans.

Types

Fructans

In experimental probiotic psychobiotics, the bacteria most commonly used are gram-positive bacteria, such as Bifidobacterium and Lactobacillus families, as these do not contain lipopolysaccharide chains, reducing the likelihood of an immunological response. Prebiotics are substances, such as fructans and oligosaccharides, that induce the growth or activity of beneficial microorganisms, such as bacteria on being fermented in the gut. Multiple bacterial species contained in a single probiotic broth is known as a polybiotic.

Gut-brain axis

Psychobiotics are probiotics that influence the gut-brain axis, the bidirectional communication network linking the gastrointestinal system and the brain. By positively modulating the gut microbiota, psychobiotics can impact the production of neurotransmitters, reduce inflammation, and enhance neural signaling, which may improve mental health and alleviate symptoms of neurological disorders. This highlights their potential as a therapeutic tool for maintaining a healthy gut-brain connection.

Research

A 2021 review showed that treating anxiety in young people with psychobiotics had no significant effect. This study highlights the gut microbiome's role in brain function and mental health is a growing research area, particularly during adolescence, a critical period for gut-brain axis development. This study systematically reviewed and analyzed the effects of psychobiotic interventions on anxiety in youth (ages 10–24). Among 5416 studies identified, 14 were reviewed, and 10 included in the meta-analysis, involving 617 participants. The results showed minimal efficacy of psychobiotics in reducing anxiety, with a pooled standard mean difference of −0.03, indicating no significant effect. Despite limited evidence, future research focusing on mechanisms, causality, and youth perspectives is essential for advancing psychobiotic use in mental health management.

Another 2022 article highlights how the nervous system disorders affect millions globally each year, sparking interest in the potential of probiotics to support the gut-brain axis alongside traditional treatments. Psychobiotics, a type of probiotic, have shown promise in improving gut microbiota and alleviating symptoms of central nervous system (CNS) disorders. This study reviewed their impact on conditions like autism spectrum disorders, Parkinson's disease, multiple sclerosis, depression, and insomnia, among others. The findings suggest that psychobiotic-containing functional foods could be an effective tool for improving mental health and managing CNS disorders.

There is a need for more diverse human studies, mainly because those that exist have contradictory outcomes.

Species

Lactobacillus acidophilus

Several species of bacteria have been used in probiotic psychobiotic research:

References

  1. ^ Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PW (November 2016). "Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals". Trends in Neurosciences. 39 (11): 763–81. doi:10.1016/j.tins.2016.09.002. PMC 5102282. PMID 27793434.
  2. Del Toro-Barbosa, M.; Hurtado-Romero, A.; Garcia-Amezquita, L. E.; García-Cayuela, T. (2020). "Psychobiotics: Mechanisms of Action, Evaluation Methods and Effectiveness in Applications with Food Products". Nutrients. 12 (12): 3896. doi:10.3390/nu12123896. PMC 7767237. PMID 33352789.
  3. ^ Romijn AR, Rucklidge JJ (October 2015). "Systematic review of evidence to support the theory of psychobiotics". Nutrition Reviews. 73 (10): 675–93. doi:10.1093/nutrit/nuv025. PMID 26370263.
  4. ^ Liu B, He Y, Wang M, Liu J, Ju Y, Zhang Y, Liu T, Li L, Li Q (July 2018). "Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials". Depression and Anxiety. 35 (10): 935–45. doi:10.1002/da.22811. PMID 29995348. S2CID 51615532.
  5. Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G, Goh YJ, Hamaker B, Martens EC, Mills DA, Rastal RA, Vaughan E, Sanders ME (February 2016). "Prebiotics: why definitions matter". Current Opinion in Biotechnology. 37: 1–7. doi:10.1016/j.copbio.2015.09.001. PMC 4744122. PMID 26431716.
  6. ^ Bambury A, Sandhu K, Cryan JF, Dinan TG (December 2018). "Finding the needle in the haystack: systematic identification of psychobiotics". British Journal of Pharmacology. 175 (24): 4430–38. doi:10.1111/bph.14127. PMC 6255950. PMID 29243233.
  7. ^ Cohen Kadosh, Kathrin; Basso, Melissa; Knytl, Paul; Johnstone, Nicola; Lau, Jennifer Y. F.; Gibson, Glenn R. (2021-06-16). "Psychobiotic interventions for anxiety in young people: a systematic review and meta-analysis, with youth consultation". Translational Psychiatry. 11 (1): 352. doi:10.1038/s41398-021-01422-7. ISSN 2158-3188. PMC 8206413. PMID 34131108.
  8. Dinan TG, Stanton C, Cryan JF (November 2013). "Psychobiotics: a novel class of psychotropic". Biological Psychiatry. 74 (10): 720–26. doi:10.1016/j.biopsych.2013.05.001. PMID 23759244. S2CID 40059439.

Further reading

  • Anderson, Scott C.; Cryan, John F.; Dinan, Ted (17 December 2019). The Psychobiotic Revolution (1 ed.). Random House US. ISBN 9781426219641.
Dietary supplements
Types
Vitamins and
chemical elements
("minerals")
Other common
ingredients
Related articles
Categories: